Comparing highly efficacious antimalarial drugs
- PMID: 19018659
- PMCID: PMC2586357
- DOI: 10.1371/journal.pmed.0050228
Comparing highly efficacious antimalarial drugs
Abstract
Colin Sutherland discusses a Policy Forum article that explores the design and standardization of pre-licensure phase III antimalarial treatment trials.
Conflict of interest statement
Comment on
-
Revisiting the design of phase III clinical trials of antimalarial drugs for uncomplicated Plasmodium falciparum malaria.PLoS Med. 2008 Nov 18;5(11):e227. doi: 10.1371/journal.pmed.0050227. PLoS Med. 2008. PMID: 19018658 Free PMC article.
References
-
- White NJ, Nosten F, Looareesuwan S, Watkins WM, Marsh K, et al. Averting a malaria disaster. Lancet. 1999;353:1965–1967. - PubMed
-
- Borrmann S, Peto T, Snow RW, Gutteridge W, White NJ. Revisiting the design of phase III clinical trials of antimalarial drugs for uncomplicated Plasmodium falciparum malaria. PLoS Med. 2008;5:e227. doi: 10.1371/journal.pmed.0050227. - DOI - PMC - PubMed
-
- Laufer MK, Djimdé AA, Plowe CV. Monitoring and deterring drug-resistant malaria in the era of combination therapy. Am J Trop Med Hyg. 2007;77:160–169. - PubMed
-
- Sutherland CJ, Ord R, Dunyo S, Jawara M, Drakeley CJ, et al. Reduction of malaria transmission to Anopheles mosquitoes with a six-dose regimen of co-artemether. PLoS Med. 2005;2:e92. doi: 10.1371/journal.pmed.0020092. - DOI - PMC - PubMed
-
- Hallett RL, Dunyo S, Ord R, Jawara M, Pinder M, et al. Chloroquine/sulphadoxine-pyrimethamine for Gambian children with malaria: Transmission to mosquitoes of multidrug-resistant Plasmodium falciparum . PLoS Clin Trial. 2006;1:e15. doi: 10.1371/journal.pctr.0010015. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
